- 英文名称
- Deflazacort
- 分子式
- C25H31NO6
- 分子量
- 441.52
- 中文别名
- 地那查可特; 地氟可特; 去氟可特; (1LΒ,16Β)-21-乙酰氧基-11-羟基-2'-甲基-5'H-娠烷-1,4-二烯并[17,16-D]噁唑-3,20二酮; 地恶唑可特; 地拉扎可; 2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-Hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-6b-yl]-2-oxoethyl acetate; 11b,21-Dihydroxy-2'-methyl-5'bH-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione 21-acetate; Pregna-1,4-diene-11b,21-diol-3,20-dione[17a,16a-d]-2'-methyloxazoline 21-Acetate; Calcort; DL 458-IT; (11b,16b)-21-(Acetyloxy)-11-hydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione; Dezacor; Lantadin; Cortax; Decortil; Deflanil; Deflan; Flantadin; Azacort; Emflaza; Deflazacortum; MDL 458; DL-458IT; Oxazacort; Denazacort
- 用途
- 第三代糖皮质激素，有消炎、抗过敏、增加糖原异生等作用；用于原发及继发性肾上腺皮质功能减退、风湿病、胶原性疾病、皮肤病、变应性疾病、眼科疾病、暴发性和播散性肺结核、造血系统疾患、溃疡性结肠炎、特发性肾病综合征、造血系统恶性肿瘤等。
